PharmEco Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing
- Coordinator
- Universiteit Gent, Belgium
- Runs
- 1 November 2024 to 31 October 2030
- Status
- Running
- EU funding
- €16.0m
- Total cost
- €34.4m
- Partners
- 54 organisations in 14 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101165889
What the project is doing
In the project's own words, from its summary on CORDIS.
PHARMECO is supported by the Innovative Health Initiative Joint Undertaking (IHI JU). The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe. The project's overall objective is to revolutionize pharmaceutical manufacturing towards sustainability by integrating environmentally friendly technologies/processes and harmonized sustainability assessments methods into healthcare industry practices.
This encompasses early design phase, operation, and eventual use and disposal. The project's first objective is to enhance the early-stage development of pharmaceutical products by implementing Sustainable-by-Design (SSbD)-driven process-intensified platforms (e.g. continuous manufacturing). This involves designing sustainable processes based on so-called SELECT (Safety, Environment, Legal, Economy, Control and Throughput) criteria and setting up eco-friendly systems for producing small molecules, peptides, oligo-nucleotides, proteins and ribonucleic acid (RNA) with advanced control measures.
Next, PHARMECO aims to scale up and demonstrate environmentally-friendly processes for industrial manufacturing and decontamination, which includes creating infrastructure for studying key unit operations with sustainable technology and for SSbD-driven process intensified manufacture at a scale sufficient for clinical testing and a manufacturing process that is easily transferred to a Good Manufacturing Practice (GMP) environment.
PHARMECO also aims to steer the development of (bio)manufacturing processes towards sustainable production through digital decision-making tools. This involves creating a modular digital tool for assessing sustainability from multiple perspectives, evaluating practices. Finally, the project seeks to establish a standardized approach for assessing the environmental sustainability of pharmaceuticals, which involves collaboration with various stakeholders to create scientifically robust guidelines, applying consistent Life Cycle Assessment (LCA) methodologies, and facilitate regulatory adoption of standardized LCA practices.
By integrating sustainability considerations into every phase of manufacturing, PHARMECO will positively revolutionize pharmaceutical industry.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Gent | Gent | Belgium | Coordinator |
| Microinnova Engineering GmbH | Allerheiligen bei Wildon | Austria | Participant |
| Research Center Pharmaceutical Engineering GmbH | Graz | Austria | Participant |
| Universitaet Graz | Graz | Austria | Participant |
| Janssen Pharmaceutica NV | Beerse | Belgium | Participant |
| Swiftpharma BV | Gent | Belgium | Participant |
| Ucb Biopharma | Bruxelles / Brussel | Belgium | Participant |
| Vtu Engineering Belgium BV | Mechelen | Belgium | Participant |
| Ares Trading SA | Coinsins | Switzerland | Associatedpartner |
| Ucb Farchim SA | Bulle | Switzerland | Associatedpartner |
| Abbvie Deutschland GmbH & Co Kg | Wiesbaden | Germany | Associatedpartner |
| Boehringer Ingelheim Internationalgmbh | Ingelheim | Germany | Participant |
| Boehringer Ingelheim Pharma GmbH &co Kg | Ingelheim | Germany | Associatedpartner |
| Merck Electronics Kgaa | Darmstadt | Germany | Associatedpartner |
| Merck Healthcare Kgaa | Darmstadt | Germany | Associatedpartner |
| Merck Kommanditgesellschaft Auf Aktien | Darmstadt | Germany | Participant |
| Merck Life Science Kgaa | Darmstadt | Germany | Associatedpartner |
| Sanofi-Aventis Deutschland GmbH | Frankfurt Am Main | Germany | Participant |
| Technische Universitat Berlin | Berlin | Germany | Participant |
| UCB BioSciences GMBH | Monheim am Rhein | Germany | Associatedpartner |
| Novo Nordisk A/s | Bagsvaerd | Denmark | Participant |
| Aimplas - Asociacion De Investigacion De Materiales Plasticos Y Conexas | Paterna | Spain | Participant |
| Cultzyme SL | Donostia - San Sebastian | Spain | Participant |
| Benkei | Lyon | France | Participant |
| Institut De Recherches Internationales Servier | Gif-Sur-Yvette | France | Participant |
| Oril Industrie | Bolbec | France | Associatedpartner |
| Sanofi Winthrop Industrie | Gentilly | France | Associatedpartner |
| Sanofi-Aventis Recherche & Developpement | Gentilly | France | Associatedpartner |
| Sfe Process | Villers-Les-Nancy | France | Participant |
| Sofradim Production Sasu | Trevoux | France | Participant |
| Pfizer Ireland Pharmaceuticals | Cork | Ireland | Associatedpartner |
| Pfizer Healthcare India Private Limited | TamilNadu | India | Associatedpartner |
| Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. | Colleretto Giacosa | Italy | Associatedpartner |
| Merck Serono SpA | Roma | Italy | Associatedpartner |
| Pfizer Italia s.r.l. | Latina | Italy | Associatedpartner |
| Rijksinstituut Voor Volksgezondheid En Milieu (rivm) | Bilthoven | Netherlands | Participant |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Ucb Pharma B.v. | Breda | Netherlands | Associatedpartner |
| Lifeclean International AB | Uddevalla | Sweden | Participant |
| Rise Processum AB | Ornskoldsvik | Sweden | Participant |
| Rise Research Institutes of Sweden AB | Boras | Sweden | Participant |
| Astrazeneca UK Limited | Cambridge | United Kingdom | Participant |
| Biotoolomics Limited | Consett | United Kingdom | Associatedpartner |
| Centre for Process Innovation Limited Lbg | Redcar Cleveland | United Kingdom | Associatedpartner |
| Glaxosmithkline Research & Development Limited | London | United Kingdom | Participant |
| Loughborough University | Loughborough | United Kingdom | Associatedpartner |
| Pfizer Limited | Sandwich | United Kingdom | Associatedpartner |
| Pfizer R&D UK Limited | Sandwich | United Kingdom | Associatedpartner |
| UCB celltech pharmaceuticals | Slough | United Kingdom | Associatedpartner |
| Abbvie Inc | North Chicago Il | United States | Participant |
| AstraZeneca Pharmaceuticals LP | Wilmington | United States | Associatedpartner |
| Pfizer Inc | New York City | United States | Participant |
| Sanofi Genzyme | Cambridge | United States | Associatedpartner |
| Sanofi US Services Inc. | Cambridge, Massachusetts | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI